Advanced search
Publication Cover
Journal of Medical Economics Volume 19, 2016 - Issue 12
Submit an article Journal homepage
1,703
Views
5
CrossRef citations to date
0
Altmetric
Urology

Economic impact of onabotulinumtoxinA for overactive bladder with urinary incontinence in Europe

Lewis RuffCovance - Market Access Services, Butlers Wharf, London, UK; Correspondence[email protected]
,
Emma BagshawCovance - Market Access Services, Butlers Wharf, London, UK;
,
Javier AracilAllergan Holdings Limited - Pricing Reimbursement and Market Access, Marlow, UK
,
Marie-Eve VelardAllergan Holdings Limited - Pricing Reimbursement and Market Access, Marlow, UK
,
Gianni PardhananiAllergan Holdings Limited - Pricing Reimbursement and Market Access, Marlow, UK
&
Zsolt HeppAllergan Holdings Limited - Pricing Reimbursement and Market Access, Marlow, UK
Pages 1107-1115 | Received 18 Feb 2016, Accepted 18 May 2016, Published online: 15 Jul 2016

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Daniel Bin Ng, Robert Espinosa, Scott J. Johnson, David Walker & Katherine Gooch. (2017) The impact of persistence with mirabegron usage vs switching to onabotulinumtoxinA on healthcare costs and resource utilization in patients with overactive bladder in the United States. Journal of Medical Economics 20:12, pages 1272-1280.
Read now

Articles from other publishers (4)

Li June Tay, Deepak Harry, Sachin Malde & Arun Sahai. (2021) Cost Effectiveness of Sacral Neuromodulation and OnabotulinumtoxinA in Managing Refractory Idiopathic Overactive Bladder. Urology 149, pages 1-10.
Crossref
David Sheyn, Mingxuan Ju, Sixiao Zhang, Caleb Anyaeche, Adonis Hijaz, Jeffrey Mangel, Sangeeta Mahajan, Britt Conroy, Sherif El-Nashar & Soumya Ray. (2019) Development and Validation of a Machine Learning Algorithm for Predicting Response to Anticholinergic Medications for Overactive Bladder Syndrome. Obstetrics & Gynecology 134:5, pages 946-957.
Crossref
Said M. Yaiesh, Meshari F. Almutairi, Abdullatif E. Al-Terki & Tariq F. Al-Shaiji. 2018. Botulinum Toxin. Botulinum Toxin.
Fabiola R Tamburro, Pietro Castellan, Fabio Neri, Francesco Berardinelli, Maida Bada, Petros Sountoulides, Nicola Giuliani, Enrico Finazzi Agrò, Luigi Schips & Luca Cindolo. (2018) Onabotulinumtoxin-A improves health status and urinary symptoms in subjects with refractory overactive bladder: Real-life experience. Urologia Journal 85:4, pages 163-168.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.